Products & Services · Total revenues
Total TTR — Total revenues
Alnylam Pharmaceuticals Total TTR — Total revenues increased by 6.1% to $910.41M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 153.3%, from $359.48M to $910.41M. Over 2 years (FY 2023 to FY 2025), Total TTR — Total revenues shows an upward trend with a 65.1% CAGR.
Analysis
Metric ID:
alny_segment_total_ttr_total_revenuesHistorical Data
13 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $228.1M | $228.1M | $228.1M | $228.1M | $264.46M | $307.35M | $308.88M | $342.61M | $359.48M | $544.49M | $724.38M | $858.28M | $910.41M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +15.9% | +16.2% | +0.5% | +10.9% | +4.9% | +51.5% | +33.0% | +18.5% | +6.1% |
| YoY Change | — | — | — | — | +15.9% | +34.7% | +35.4% | +50.2% | +35.9% | +77.2% | +134.5% | +150.5% | +153.3% |
Range$228.1M – $910.41M
CAGR+58.6%
Avg YoY Growth+76.4%
Median YoY Growth+50.2%
Current Streak12+ quarters growth
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's total ttr — total revenues?
- Alnylam Pharmaceuticals (ALNY) reported total ttr — total revenues of $910.41M in Q1 2026.
- How has Alnylam Pharmaceuticals's total ttr — total revenues changed year-over-year?
- Alnylam Pharmaceuticals's total ttr — total revenues increased by 153.3% year-over-year, from $359.48M to $910.41M.
- What is the long-term trend for Alnylam Pharmaceuticals's total ttr — total revenues?
- Over 2 years (2023 to 2025), Alnylam Pharmaceuticals's total ttr — total revenues has grown at a 65.1% compound annual growth rate (CAGR), from $912.38M to $2.49B.